Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.76 |
| ▸ | ALPI | P09923 | 1/20 | 0.76 |
| ▸ | PKM | P14618 | 1/20 | 0.76 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.76 |
| ▸ | XIAP | P98170 | 1/20 | 0.76 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.63 |
| ▸ | LTA4H | P09960 | 2/20 | 0.59 |
| ▸ | ANPEP | P15144 | 2/20 | 0.58 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.58 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.58 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.58 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.58 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | LAP3 | P28838 | 3/20 | 0.53 |
| ▸ | CTSC | P53634 | 1/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL660503 | 1.00 | SLC7A5 (0.76) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL9266010 | 0.91 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL15295143 | 0.90 | SLC7A5 (0.70) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL17305093 | 0.90 | SLC7A5 (0.63) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL29169576 | 0.90 | ALPI (0.68) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL7365811 | 0.90 | SLC7A5 (0.68) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL1788900 | 0.90 | SLC7A5 (0.68) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL16628200 | 0.90 | ALPI (0.68) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL19539172 | 0.89 | ALPI (0.61) | SLC7A5ALPIPKMPTGS1XIAP | |
| SCHEMBL23159186 | 0.86 | SLC7A5 (1.00) | SLC7A5ALPIPKMPTGS1XIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117417526-A | Conductive polymer coated super-crosslinked porous polymer wave absorber and preparation method thereof | 烟台哈尔滨工程大学研究院 | 2024-01-19 | — | — | CN | disclosed |
| US-9259479-B2 | Treatment for comorbid diabetes with chronic kidney disease | ELI LILLY AND COMPANY (US) | 2016-02-16 | — | — | US | disclosed |
| US-20150343080-A1 | GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS | NOVO NORDISK AS (DK) | 2015-12-03 | — | — | US | disclosed |
| US-20150111819-A1 | TREATMENT FOR COMORBID DIABETES WITH CHRONIC KIDNEY DISEASE | ELI LILLY AND COMPANY | 2015-04-23 | — | — | US | disclosed |
| US-20120045393-A1 | LHRH-II PEPTIDE ANALOGS | BRACCO IMAGING SPA (IT) | 2012-02-23 | — | — | US | disclosed |
| WO-2010107832-A1 | LHRH-II PEPTIDE ANALOGS | BRACCO IMAGING SPA (IT) | 2010-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150111819-A1 | TREATMENT FOR COMORBID DIABETES WITH CHRONIC KIDNEY DISEASE | GLP1R, SLC5A2, GPR119 | SLC7A5 1732/4885ALPI 1192/4885PKM 1484/4885 |
| US-20120045393-A1 | LHRH-II PEPTIDE ANALOGS | LHCGR, GNRHR, FSHR | SLC7A5 3395/4885ALPI 2692/4885PKM 1851/4885 |
| US-20150343080-A1 | GLYCOPEGYLATION METHODS AND PROTEINS/PEPTIDES PRODUCED BY THE METHODS | PTMS, ANPEP, NGLY1 | SLC7A5 2516/4885ALPI 3619/4885PKM 3878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.